We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Filings, earnings, research, and institutional changes — newest first
EPS 컨센서스 1.61 · 매출 컨센서스 113억. 발표 후 실제치와 비교하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
A material-event filing was submitted. Check the category (guidance / executives / M&A, etc.).
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
신규 편입 · 포트폴리오 비중 0.13%
신규 편입 · 포트폴리오 비중 0.52%
신규 편입 · 포트폴리오 비중 0.24%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
A quarterly report was filed. Review revenue/cost trends and guidance changes.
A material-event filing was submitted. Check the category (guidance / executives / M&A, etc.).
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.
US analyst rating / recommendation change.
An insider trade (Form 4) was filed.